Skip to main content

Cardiovascular & Hematological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders) was previously published as Current Drug Targets - Cardiovascular & Hematological Disorders.

Publisher: Bentham Science Publishers

Volume 9, Number 4, December 2009

Articles

Favourites:
ADD

Odontogenic Infections in the Etiology of Infective Endocarditis
pp. 231-235(5)
Authors: Bascones-Martinez, Antonio; Munoz-Corcuera, Marta; Meurman, Jukka H.

Favourites:
ADD

Prevention of Bacterial Endocarditis
pp. 236-239(4)
Authors: Mazokopakis, Elias E.; Karefilakis, Christos M.; Starakis, Ioannis K.

Favourites:
ADD

Complications of Infective Endocarditis
pp. 240-248(9)
Authors: Mocchegiani, R.; Nataloni, M.

Favourites:
ADD

Prosthetic Valve Endocarditis: Diagnostic Approach and Treatment Options
pp. 249-260(12)
Authors: Starakis, Ioannis; Mazokopakis, Elias E.

Favourites:
ADD

Update on the Treatments of Non-Alcoholic Fatty Liver Disease (NAFLD)
pp. 261-270(10)
Authors: Quercioli, Alessandra; Montecucco, Fabrizio; Mach, Francois

Favourites:
ADD

Free Content A Systems Biology Consideration of the Vasculopathy of Sickle Cell Anemia: The Need for Multi-Modality Chemo-Prophylaxis
pp. 271-292(22)
Authors: Hebbel, Robert P.; Vercellotti, Greg M.; Nath, Karl A.

Favourites:
ADD

CD44 - a New Cardiovascular Drug Target or Merely an Innocent Bystander?
pp. 293-302(10)
Authors: Krettek, Alexandra; Sjoberg, Sara

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more